title: Exploiting the molecular template of angiotensinogen in the discovery and design of peptidyl, pseudopeptidyl and peptidimimetic inhibitors of human renin: a structure-activity perspective.
authors.affiliation: Upjohn Laboratories, Upjohn Company, Kalamazoo, Michigan 49001.
authors.forename: T K
authors.initials: TK
authors.lastname: Sawyer
authors.forename: J B
authors.initials: JB
authors.lastname: Hester
authors.forename: H J
authors.initials: HJ
authors.lastname: Schostarez
authors.forename: S
authors.initials: S
authors.lastname: Thaisrivongs
authors.forename: G L
authors.initials: GL
authors.lastname: Bundy
authors.forename: L
authors.initials: L
authors.lastname: Liu
authors.forename: V S
authors.initials: VS
authors.lastname: Bradford
authors.forename: A E
authors.initials: AE
authors.lastname: De Vaux
authors.forename: D J
authors.initials: DJ
authors.lastname: Staples
authors.forename: L L
authors.initials: LL
authors.lastname: Maggiora
mesh_terms: D000595:Amino Acid Sequence; D000808:Angiotensinogen / Q000031:analogs & derivatives / Q000737:chemistry* / Q000494:pharmacology; D001665:Binding Sites; D006801:Humans; D066298:In Vitro Techniques; D008958:Models, Molecular; D008969:Molecular Sequence Data; D012083:Renin / Q000737:chemistry; D013329:Structure-Activity Relationship; D013379:Substrate Specificity; D000092502:Renin Inhibitors
chemical_list: D000808:Angiotensinogen; D012083:Renin; D000092502:Renin Inhibitors